Clinical Trial Update: A Study to Evaluate AZP531 in Healthy Volunteers, Overweight/Obese Volunteers and Patients With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating AZP531 in healthy volunteers, overweight/obese individuals, and patients with Type 2 Diabetes Mellitus, sponsored by Alizé Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Type 2 Diabetes Mellitus

Drugs mentioned

• AZP531

Snippet

Sponsor: Alizé Pharma | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN